tiprankstipranks
Takeda Pharmaceutical Co Ltd (TKPHF)
OTHER OTC:TKPHF
US Market
TKPHF
Takeda Pharmaceutical Co
RESEARCH TOOLSreports

Takeda Pharmaceutical Co (TKPHF) Ratios

36 Followers

Takeda Pharmaceutical Co Ratios

TKPHF's free cash flow for Q1 2026 was ¥0.67. For the 2026 fiscal year, TKPHF's free cash flow was decreased by ¥ and operating cash flow was ¥0.19. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 1.14 1.27 1.01 1.11 0.97
Quick Ratio
 0.62 0.70 0.52 0.58 0.57
Cash Ratio
 0.17 0.24 0.09 0.09 0.09
Solvency Ratio
 0.11 0.12 0.12 0.11 0.13
Operating Cash Flow Ratio
 0.32 0.39 0.38 0.28 0.35
Short-Term Operating Cash Flow Coverage
 1.72 1.83 1.57 1.48 2.20
Net Current Asset Value
¥ -4.95T¥ -4.59T¥ -4.79T¥ -5.28T¥ -5.21T
Leverage Ratios
Debt-to-Assets Ratio
 0.32 0.32 0.36 0.36 0.35
Debt-to-Equity Ratio
 0.65 0.63 0.73 0.75 0.77
Debt-to-Capital Ratio
 0.40 0.39 0.42 0.43 0.43
Long-Term Debt-to-Capital Ratio
 0.37 0.36 0.36 0.38 0.39
Financial Leverage Ratio
 2.07 1.99 2.05 2.08 2.20
Debt Service Coverage Ratio
 1.40 1.46 1.33 1.74 2.10
Interest Coverage Ratio
 1.55 1.51 3.36 3.46 4.83
Debt to Market Cap
 0.56 0.55 0.66 0.75 0.66
Interest Debt Per Share
 3.36K 3.33K 3.34K 3.59K 3.22K
Net Debt to EBITDA
 3.56 3.20 4.31 5.67 3.91
Profitability Margins
Gross Profit Margin
62.15%51.06%53.59%54.53%57.07%
EBIT Margin
12.70%13.71%7.99%4.69%12.91%
EBITDA Margin
27.22%29.72%24.61%21.76%29.41%
Operating Profit Margin
10.52%11.99%13.70%12.46%16.34%
Pretax Profit Margin
5.89%5.77%3.82%1.24%9.31%
Net Profit Margin
3.91%4.26%2.36%3.38%7.87%
Continuous Operations Profit Margin
3.92%4.26%2.36%3.38%7.87%
Net Income Per EBT
66.37%73.70%61.64%272.90%84.52%
EBT Per EBIT
56.03%48.14%27.90%9.93%56.98%
Return on Assets (ROA)
1.15%1.24%0.76%0.95%2.27%
Return on Equity (ROE)
2.40%2.47%1.56%1.98%4.99%
Return on Capital Employed (ROCE)
3.77%4.15%5.34%4.15%5.74%
Return on Invested Capital (ROIC)
2.41%2.95%3.14%4.02%4.69%
Return on Tangible Assets
2.83%3.08%2.04%2.66%6.47%
Earnings Yield
2.08%2.15%1.55%2.21%4.70%
Efficiency Ratios
Receivables Turnover
 4.83 5.14 6.32 6.11 5.91
Payables Turnover
 3.91 4.49 6.89 6.06 5.62
Inventory Turnover
 1.21 1.58 1.75 1.60 1.75
Fixed Asset Turnover
 2.16 2.12 2.33 2.14 2.38
Asset Turnover
 0.29 0.29 0.32 0.28 0.29
Working Capital Turnover Ratio
 8.83 13.34 35.22 52.80 22.13
Cash Conversion Cycle
 284.41 220.84 213.80 227.25 205.11
Days of Sales Outstanding
 75.56 70.99 57.78 59.72 61.78
Days of Inventory Outstanding
 302.13 231.17 208.96 227.76 208.23
Days of Payables Outstanding
 93.27 81.33 52.95 60.23 64.90
Operating Cycle
 377.69 302.16 266.74 287.48 270.01
Cash Flow Ratios
Operating Cash Flow Per Share
 572.70 595.98 609.61 409.29 565.29
Free Cash Flow Per Share
 448.15 484.24 482.43 297.17 474.65
CapEx Per Share
 124.56 111.74 127.18 112.13 90.64
Free Cash Flow to Operating Cash Flow
 0.78 0.81 0.79 0.73 0.84
Dividend Paid and CapEx Coverage Ratio
 1.75 1.92 1.91 1.38 2.09
Capital Expenditure Coverage Ratio
 4.60 5.33 4.79 3.65 6.24
Operating Cash Flow Coverage Ratio
 0.18 0.19 0.19 0.12 0.18
Operating Cash Flow to Sales Ratio
 0.19 0.21 0.21 0.15 0.22
Free Cash Flow Yield
7.92%8.55%10.93%7.15%10.91%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 48.97 46.52 64.56 45.16 21.29
Price-to-Sales (P/S) Ratio
 1.93 1.98 1.52 1.53 1.68
Price-to-Book (P/B) Ratio
 1.16 1.15 1.00 0.89 1.06
Price-to-Free Cash Flow (P/FCF) Ratio
 12.71 11.70 9.15 14.00 9.16
Price-to-Operating Cash Flow Ratio
 9.77 9.50 7.24 10.16 7.70
Price-to-Earnings Growth (PEG) Ratio
 1.59 0.60 -2.51 -0.82 0.55
Price-to-Fair Value
 1.16 1.15 1.00 0.89 1.06
Enterprise Value Multiple
 10.64 9.86 10.49 12.68 9.61
Enterprise Value
 13.33T 13.21T 11.82T 11.76T 11.38T
EV to EBITDA
 10.60 9.86 10.49 12.68 9.61
EV to Sales
 2.88 2.93 2.58 2.76 2.83
EV to Free Cash Flow
 19.03 17.32 15.52 25.31 15.45
EV to Operating Cash Flow
 14.89 14.07 12.28 18.37 12.98
Tangible Book Value Per Share
 -1.10K -922.86 -1.28K -1.54K -1.74K
Shareholders’ Equity Per Share
 4.84K 4.94K 4.39K 4.65K 4.09K
Tax and Other Ratios
Effective Tax Rate
 0.34 0.26 0.38 -1.73 0.15
Revenue Per Share
 2.96K 2.86K 2.90K 2.73K 2.60K
Net Income Per Share
 115.65 121.75 68.36 92.09 204.29
Tax Burden
 0.66 0.74 0.62 2.73 0.85
Interest Burden
 0.46 0.42 0.48 0.26 0.72
Research & Development to Revenue
 0.15 0.15 0.16 0.17 0.16
SG&A to Revenue
 0.24 0.24 0.24 0.00 0.00
Stock-Based Compensation to Revenue
 0.01 0.00 0.00 0.00 0.00
Income Quality
 4.95 4.90 8.92 4.44 2.77
Currency in JPY